Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1’015’000.00 KRW | 0.00% | +1.50% | +6.95% |
17.01. | Samsung Biologics betritt mit neuer Einrichtung den Markt für Antikörper-Wirkstoff-Konjugate | MT |
15.01. | Samsung Biologics unterzeichnet CMO-Vertrag für Biologika mit EU-Pharmaunternehmen | MT |
Zu einer Liste hinzufügen 0 ausgewählt | % | % 5 Tage | Veränderung - 1 Monat | Veränderung - 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 J. | Veränd. 5 J. | Veränd. 10 J. | Kap. ($) | |
---|---|---|---|---|---|---|---|---|---|---|---|
0.00% | +1.50% | +8.09% | +1.50% | +6.95% | +31.82% | +24.39% | +131.74% | - | 50.21 Mrd. | ||
-0.42% | -2.35% | -1.14% | -9.04% | -2.90% | -5.39% | +0.80% | -9.90% | +226.43% | 83.25 Mrd. | ||
-0.11% | -3.30% | -4.46% | +5.26% | -4.73% | +117.51% | +100.90% | +124.83% | +164.18% | 36.13 Mrd. | ||
+0.33% | -1.20% | -5.38% | -23.46% | -7.57% | -43.08% | -35.91% | -50.79% | -60.94% | 20.48 Mrd. | ||
+1.37% | +0.76% | +3.78% | +11.05% | +4.94% | +17.85% | -3.09% | -7.84% | -6.39% | 13.86 Mrd. | ||
+0.31% | -0.18% | +50.79% | +64.69% | +51.66% | +88.15% | +196.92% | +398.09% | +541.34% | 13.41 Mrd. | ||
-0.98% | -0.10% | -10.35% | -5.39% | -2.92% | +1.77% | -37.45% | - | - | 11.97 Mrd. | ||
+1.47% | -2.17% | -5.80% | -11.18% | -5.03% | -33.62% | -26.26% | -28.70% | -35.07% | 11.73 Mrd. | ||
+3.58% | +6.52% | +14.98% | -17.59% | +2.91% | +321.30% | +557.83% | +1’694.37% | +6’624.93% | 11.8 Mrd. | ||
+1.81% | +5.16% | +8.75% | +6.29% | +6.49% | +15.44% | +84.50% | +81.43% | +303.34% | 10.34 Mrd. | ||
+0.04% | +1.55% | -11.68% | -23.52% | -5.44% | -49.74% | -65.14% | -38.34% | +249.79% | 8.15 Mrd. | ||
+0.81% | -9.67% | -10.70% | -31.28% | -14.48% | -8.75% | -25.12% | -1.57% | - | 6.54 Mrd. | ||
+2.94% | -4.11% | +22.94% | +35.69% | +24.42% | -10.25% | +231.46% | +5.93% | - | 6.39 Mrd. | ||
+0.15% | +3.32% | -5.26% | -5.39% | -5.26% | -0.87% | -5.39% | -8.19% | -46.34% | 6.19 Mrd. | ||
-0.21% | -1.95% | -3.98% | -11.64% | -3.41% | +0.23% | -46.82% | -71.98% | -50.00% | 5.73 Mrd. | ||
+7.01% | +8.36% | -0.10% | -5.21% | +1.22% | -10.30% | +1.29% | +19.40% | +137.63% | 5.25 Mrd. | ||
+2.70% | +10.65% | +7.66% | +2.31% | +10.64% | +2.96% | +294.90% | +5.50% | - | 4.46 Mrd. | ||
-0.64% | +11.40% | +12.49% | -4.12% | +8.72% | +42.65% | +176.31% | +86.16% | - | 4.47 Mrd. | ||
-0.13% | +1.16% | -11.56% | -3.02% | -6.47% | -17.23% | -43.17% | -42.27% | +35.27% | 3.95 Mrd. | ||
+0.62% | -0.67% | -8.52% | +3.78% | -5.48% | +206.43% | +1’017.93% | +265.09% | +47.36% | 3.79 Mrd. | ||
Durchschnitt | +1.07% | +2.30% | +2.53% | -1.01% | +2.71% | +33.34% | +119.94% | +134.37% | +580.82% | 15.9 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | +0.43% | +0.35% | +2.47% | -1.84% | +1.77% | +30.97% | +62.16% | +116.25% | +487.47% |
- Börse
- Aktien
- A207940 Aktie
- Sektor Samsung Biologics Co.,Ltd.
MarketScreener is also available in this country: United States.
Switch edition